A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Doctors favor treatment with continuous positive airway pressure (CPAP) machines, researchers are slated to report this week ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Kumar emphasized the importance of working with a physician to choose a weight-loss medication that matches the patient’s personal goals and health status. "Both Wegovy and Zepbound have ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed ...